David A. Siegel Fibrogen Inc Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Fibrogen Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,204,300 shares of FGEN stock, worth $1.07 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,204,300
Previous 1,800,400
33.11%
Holding current value
$1.07 Million
Previous $1.6 Million
76.65%
% of portfolio
0.01%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding FGEN
# of Institutions
120Shares Held
62.2MCall Options Held
1.54MPut Options Held
221K-
Primecap Management CO Pasadena, CA14.4MShares$12.8 Million0.03% of portfolio
-
Armistice Capital, LLC New York, NY7.94MShares$7.06 Million0.25% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$6.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.44MShares$5.73 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.5MShares$2.23 Million0.02% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $83.4M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...